Fig. 2
From: TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
TRMT6 promoted the proliferation of HCC cells and increased the proportion of S phase cells. HepG2 cells were divided into control group, OE-TRMT6 group, and shTRMT6 group. A Cell activity was used to detect by CCK-8 assay. **P < 0.01 vs control. B EDU cell proliferation detection was used to detect the number of EDU positive cells. C, D Effect of TRMT6 expression on HepG2 cell cycle distribution was detected by flow cytometry. **P < 0.01 vs control group. E Expression of p-PI3K, p-AKT and p-mTOR in HepG2 cells were detected by Western blot